The Council for Continuing Pharmaceutical Education (CCPE) is a not-for-profit organization created over 50 years ago to provide high-quality, relevant insights, community & educational programs supporting individuals and organizations in the pharmaceutical industry in Canada. CCPE has been the gold standard for continued education in the pharmaceutical industry, offering unbiased training programs developed by world-renowned industry specialists. Our independence allows us to provide assistance to industry employees and stakeholders allowing us to take an active role in continuous professional development. We offer Corporate Membership to pharmaceutical and biotech companies involved in the marketing of products in Canada. Our aim is to help you stay relevant and develop effective practical skills based on innovative thinking, professional ethics and industry needs. CCPE educated individuals are equipped with a higher value offering to customers, within their organization and in building their careers.
External link for Council for Continuing Pharmaceutical Education
3333 de la Côte-Vertu Blvd.
Suite 350
St-Laurent, Quebec H4R 2N1, CA
According to recent Council for Continuing Pharmaceutical Education course registration numbers, Market Access is the fastest growing area of interest in Pharma. Get up-to-speed quickly at the CAHR MA 101 event if you aspire to get on course ... https://lnkd.in/eUZ5iTKP
#CAHR #MarketAccess101 For more information and to register, visit https://t.ly/tCcgy. Hôtel InterContinental Montréalis is pleased to offer you a special group rate. To make your reservations, visit https://t.ly/j-8Iz.
Providing important insights for all ...
“The pandemic rocked the world and produced far-reaching changes to business fundamentals that affected workers in every industry, Pharma included. By late 2023 the watershed effects of the pandemic necessitated a fresh pulse-taking of where women were in their career development in Pharma” as a followup to our 2020 report. To order your copy, visit https://lnkd.in/gWphbuqm #benchsmart
Stay on the cutting edge of Pharma’s news - as part of the CCPE Mission we are sharing a way to subscribe for free to FirstWord Pharma and their other offerings. FirstWord Pharma a trusted news and analysis service that delivers critical intelligence to life sciences professionals. Our timely news, deep analysis, expert interviews, and event-driven physician intelligence provide actionable insights related to market dynamics, competitors, regulations, and emerging trends. FirstWord is your go-to-source in helping you navigate the dynamic world of pharmaceuticals. Register at https://lnkd.in/drwRHZyd to begin receiving your newsletter. Some recent top read articles include: Merck & Co. shells out $4 billion upfront in mega ADC pact with Daiichi Sankyo Spotlight On: Five key takeaways from ESMO 2023 Roche to enter anti-TL1A space via purchase of Telavant for $7.1 billion Novo Nordisk stops Ozempic kidney outcomes study early after signs of efficacy Some upcoming content available to subscribers include: Report: Biotech in 2023 – Coming Soon: An annual review featuring top deals and financings, and investor perspectives on what's coming next in biotech. Sign up to receive this report when it is published in December. Event: Drugs That Will Shape 2024 – Join FirstWord Pharma editors on January 17th for a discussion on the drugs which are expected to be 2024’s biggest news-makers. We'll cover novel drug approvals, key clinical data readouts and trail-blazing marketed assets, offering valuable insights into the pharmaceutical market's short and long-term trends. Register here. Also, if you are interested in digital health you can explore that site here, https://lnkd.in/eHuxK9M7 Keep ahead of the pack! Jim Shea
Healthcare workers are still in the thick of it and the general public is unaware... Share a free tool: Achieving Resilience in Canadian Healthcare within your healthcare worker network !!! https://lnkd.in/g4pG-KhS
Excellent Insights on this critical topic ... take a look. It is worth it ...
BenchSmart is pleased to release an update of its popular study on The Patient-as-Partner approach in Canadian Pharma. For your copy, visit: www.BenchSmart.ca/reports #benchsmart